The VUTORAQ brand, founded in 2002 (Sweden), from 585 sister brands and 17478 competing brands. The VUTORAQ brand is owned by ASTRAZENECA, a company listed in London. The ISIN, the company's International Securities Identification Number, is GB0009895292. The sector of VUTORAQ is Drug Manufacturers.